Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...
The 2025 Juno Award nominees are out — and with 46 awards and 208 nominees, there's a lot to take in.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback